Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults
SIMPLE SUMMARY: Outcome of patients with Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL) dramatically improved during the past 20 years with the advent of tyrosine kinase inhibitors and monoclonal antibodies. Their great efficacy in young and fit patients led to question our...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997772/ https://www.ncbi.nlm.nih.gov/pubmed/35406576 http://dx.doi.org/10.3390/cancers14071805 |